Every SEC Form 3/4/5 on record for this filer (CIK 2065881) — 1 issuer, 9 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | SVP Chief Financial Officer | 2025-05-07 → 2026-05-13 | 8 | −$149,771 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ARQT | 2026-05-11 | Sell | 435 | $21.05 | $9,157 | 85,978 |
| ARQT | 2026-05-04 | Sell | 1,341 | $23.61 | $31,661 | 86,413 |
| ARQT | 2026-03-02 | Sell | 2,772 | $25.16 | $69,744 | 87,835 |
| ARQT | 2026-03-02 | Sell | 81 | $25.91 | $2,099 | 87,754 |
| ARQT | 2026-02-02 | Sell | 1,320 | $25.50 | $33,660 | 63,607 |
| ARQT | 2025-11-03 | Sell | 88 | $24.72 | $2,175 | 64,927 |
| ARQT | 2025-08-04 | Sell | 89 | $14.33 | $1,275 | 65,015 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.